Hélène Fricker-Hidalgo

Title: Hélène Fricker-Hidalgo: Innovator in Toxoplasmosis Diagnosis

Introduction

Hélène Fricker-Hidalgo is a notable inventor based in Vaulnaveys le Haut, France. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of toxoplasmosis. His innovative approach has led to the development of a patented method that enhances the accuracy of diagnosing this condition.

Latest Patents

Fricker-Hidalgo holds a patent for "Recombinant GRA antigens and the use of same for early diagnosis of toxoplasmosis." This patent describes a method for identifying the presence or absence of anti-antibodies in human or animal serum. The process involves placing serum in contact with antigens that can bind with the anti-antibodies, followed by observing the bond or absence of a bond between antibodies and the antigens. The method utilizes a combination of two recombinant proteins, GRA2 and GRA6, which are attached to a support, such as an ELISA plate. This test is intended to supplement other diagnostic tests for toxoplasmosis.

Career Highlights

Throughout his career, Hélène Fricker-Hidalgo has worked with esteemed institutions, including Université Joseph Fourier-Grenoble 1 and Centre Hospitalier Universitaire Grenoble. His work in these organizations has allowed him to collaborate with other professionals in the field and contribute to advancements in medical diagnostics.

Collaborations

Some of his notable coworkers include Corinne Mercier and Marie-France Delauw. Their collaborative efforts have played a role in the development of innovative diagnostic methods.

Conclusion

Hélène Fricker-Hidalgo's contributions to the field of toxoplasmosis diagnosis through his patented methods demonstrate his commitment to advancing medical science. His work continues to impact the way this condition is diagnosed and managed.